April 3, 2018 / 5:06 AM / in an hour

BRIEF-‍European Commission Approves Expanded Indication For Amgen's Xgeva

Reuters Staff

1 Min Read

April 3 (Reuters) - Amgen Inc:

* ‍EUROPEAN COMMISSION APPROVES EXPANDED INDICATION FOR AMGEN’S XGEVA (DENOSUMAB) FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.